A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study)

Photodermatology Photoimmunology and Photomedicine

Volumn 24, Issue 1, 2008, Pages 38-42

  El Mofty, Medhat ^a   El Weshahy, Hany ^a   Youssef, Randa ^a   Abdel Halim, Mona ^a   Mashaly, Heba ^a   El Hawary, Marwa ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Photochemotherapy; Psoriasis; PUVA

Indexed keywords

METHOXSALEN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; OUTCOME ASSESSMENT; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; PUVA; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SKIN COLOR; SKIN PIGMENTATION; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; DRUG ADMINISTRATION SCHEDULE; FEMALE; FICUSIN; HUMANS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PSORIASIS; PUVA THERAPY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 38349032588     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2008.00334.x     Document Type: Article

References (18)

1. Burd RM. Psoriasis: A general overview. Br J Hosp Med (London) 2006; 67: 259-262.
2. Zanolli M. Phototherapy arsenal in the treatment of psoriasis. Dermatol Clin 2004; 22: 397-406, viii.
3. Tahir R, Mujtaba G. Comparison of psoralen ultraviolet A (PUVA) photochemotherapy plus topical corticosteroids with PUVA plus bland emollients in the treatment of psoriasis. J Ayub Med Coll Abbottabad 2005; 17: 34-36.
4. Melski JW, Tanenbaum L, Parrish JA. Oral methoxypsoralen photochemotherapy for the treatment of psoriasis: A cooperative clinical trial. J Invest Dermatol 1977; 68: 328-335.
5. Honigsmann H, Jaschke E, Nitsche V. Serum levels of 8-methoxypsoralen in two different drug preparations. Correlation with photosensitivity and UV-A dose requirements for photochemotherapy. J Invest Dermatol 1982; 79: 233.
6. Diette KM, Momtaz K, Stern RS, Arndt KA, Parrish JA. Psoralens and UV-A and UV-B twice weekly for the treatment of psoriasis. Arch Dermatol 1984; 134: 595-598.
7. Sakuntabhai A, Sharpe GR, Farr PM. Response of psoriasis to twice weekly PUVA. Br J Dermatol 1993; 128: 166-171.
8. Gordon PM, Diffey BL, Matthews JN, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999; 41 (5, Part 1): 728-732.
9. Markham T, Rogers S, Collins P. Narrow-band UV-B (TL-01) phototherapy vs. oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol 2003; 139: 325-328.
10. Marks R, Barton S, Shuttelworth D, Finlay AY. Assessment of disease progress in psoriasis. Arch Dermatol 1989; 125: 235-240.
11. Baumagartner TA, Strong CH. Conducting and reading research in health and human performance, 2nd edn. New York: McGraw-Hill, 1998.
12. Maier H, Schemper M, Ortel B, Binder M, Tanew A, Honigsmann H. Skin tumors in photochemotherapy for psoriasis: A single center follow-up of 496 patients. Dermatology 1996; 193: 185-191. Skin tumors in photochemotherapy for psoriasis: A single center follow-up of 496 patients
13. Morison WL, Baughman RD, Day RM, Forbes PD, Honigsman H, Krueger GG. Consensus workshop on the toxic effect of long-term PUVA therapy. Arch Dermatol 1998; 134: 595-598.
14. Stern RS, Lunder EJ. Risk of squamous cell carcinoma and methoxalen (psoralen) and UVA radiation (PUVA): A meta-analysis. Arch Dermatol 1998; 134: 1582-1585.
15. Stern RS. The PUVA follow up study. The risk of melanoma in association with long term exposure to PUVA. J Am Acad Dermatol 2001; 44: 755-761.
16. Legat FJ, Hofer A, Quehenberger F, Kahofer P, Kerl H, Wolf P. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA. J Am Acad Dermatol 2004; 51: 746-754.
17. Younes SS, Palmer RA, Garbaldinos TT, Hawk JL. Randomized double-blind trial of the treatment of chronic plaque psoriasis: Efficacy of psoralen-UV-A therapy versus narrow-band UV-B therapy. Arch Dermatol 2006; 42: 836-842.
18. Valbuena MC, Hernamdez O, Rey M, Guillermo S, de Quitana LP. Twice- vs. thrice-weekly MPD PUVA in psoriasis: A randomized-controlled efficacy study. Photodermatol Photoimmunol Photomed 2007; 23: 126-129.